Abiraterone has become the first-choice treatment for men with metastatic prostate cancer.
Robert J. Jones, MBChB, PhD
Advertisement
Articles by Robert J. Jones, MBChB, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CancerNetwork
1
FDA Approves Relacorilant Combo in Platinum-Resistant Ovarian Cancers
2
Navigating New Horizons in Neuroendocrine Prostate Cancer
3
Bevacizumab Biosimilar Shows Clinical Equivalence in Advanced NSCLC
4
Neoadjuvant Strategies and Early Biomarker Testing in EGFR-Mutated NSCLC
5